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Antioxidants and Pain Control in Patients with
Chronic Pancreatitis: A Never-Ending Story
Abstract: Chronic pancreatitis is a benign disease often characterized by recurrent episodes of abdominal pain
accompanied by progressive pancreatic exocrine and endocrine insufficiency; it sometimes requires multiple
hospitalizations. This disease is frequently the result of chronic alcohol abuse, even if other factors such as
genetic alterations, autoimmune disorders, and obstructive disease of the biliary tract and the pancreas may
cause the disease. The pain can be considered the most important symptom; it significantly modifies the quality
of life of patients with chronic pancreatitis and its control represents a challenge in the treatment of the
disease. Among the several modalities for controlling the painful symptomatology, in addition to the use of
high doses of analgesics, adding antioxidant substances to the patient’s diet has been attempted. In this paper
we review the most recent literature data about the use of antioxidants in alleviating the pancreatic pain.
Key Words: Antioxidants, pancreatitis, chronic, pain, analgesia

Department of Digestive Diseases
and Internal Medicine,
Sant’Orsola-Malpighi Hospital,
Bologna - ITALY

Antioksidanlar ve Kronik Pankreatitli Hastalarda A¤r› Kontrolü:
Bitmeyen Hikaye
Özet: Kronik pankreatit pankreas›n ilerleyici ekzokrin ve endokrin yetmezli¤i ve tekrarlayan kar›n a¤r›s›
ataklar› ile karekterize benign bir hastal›kt›r ve s›k s›k hastaneye yat›r›lmay› gerekli k›lar. Genetik de¤iﬂiklikler,
otoimmun hastal›klar ve safra yollar› ve pankreas›n t›kay›c› hastal›klar› sonucunda da oluﬂabilirse de s›kl›kla
kronik alkol kullan›m› sonucunda oluﬂur. Kronik pankreatitli hastan›n yaﬂam kalitesini de etkileyen en önemli
semptom a¤r›d›r ve a¤r›n›n kontrolü tedavideki en önemli basmakt›r. A¤r›y› kontrol etmek için yüksek doz
analjeziklerin kullan›m›na ek olarak, hastalar›n diyetlerine antioksidanlar›n eklenmesi de denenmiﬂtir. Bu
makalede pankreatik a¤r›n›n kontrolünde antioksidanlar›n kullan›m› ile ilgili literatürdeki son çal›ﬂmalar gözden
geçirilmiﬂtir.
Anahtar Sözcükler: Antioksidanlar, pankreatit, kronik, a¤r›, analjezi
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Chronic pancreatitis is a benign disease often characterized by recurrent episodes of
abdominal pain accompanied by progressive pancreatic exocrine and endocrine
insufficiency (1); it sometimes requires multiple hospitalizations. This disease is
frequently the result of chronic alcohol abuse, even if other factors such as genetic
alterations, autoimmune disorders, and obstructive disease of the biliary tract and the
pancreas may cause the disease (2). The pain can be considered the most important
symptom and it significantly modifies the quality of life of patients with chronic
pancreatitis (3). Its control represents a challenge in the treatment of the disease. Thus,
the search for a new medical approach is under investigation.

Pathophysiology of Pancreatic Pain
There are two main hypotheses regarding the origin of pain in chronic pancreatitis.
The first hypothesis, still under debate, claims that there is a correlation between
pancreatic pain and pancreatic duct changes or pressure in the duct system (4-8). The
second, also called the 'neurogenic inflammation' hypothesis, is the least convincing
theory; immunohistological reports have shown that the number of neurotransmitters,
such as substance P and its receptor, calcitonin gene-related peptide and other
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neurotransmitters, are increased in afferent pancreatic
nerves, and a correlation between pain and immune cell
infiltration of the nerves has been reported in chronic
pancreatitis (9).

Current Treatment Approaches
Medical therapy is the treatment of choice for most
patients and it is based on substitutive therapy for either
exocrine or endocrine insufficiency and on analgesics for
pain control. In the presence of intractable pain, several
therapeutic options have been applied in clinical practice
in recent years. They include endoscopic therapy (10),
thoracoscopic
splanchnicectomy
(11,12)
and
extracorporeal shockwave lithotripsy (13), even though,
in case of failure of the previous approaches, surgical
management remains the main option (14).

Medical Approaches Under Investigation: The
Antioxidant Option
Among the several modalities for controlling the
painful symptomatology, in addition to the use of high
doses of analgesics, adding antioxidant substances to the
patient’s diet has been attempted (15).
A series of clinical studies beginning in 1983 in
England in patients suffering from chronic pancreatitis
have raised hope that antioxidant supplementation may
be a step forward (15). Reviews of developments until
1996 (15,16) led to the conclusion that dietary
insufficiency of methionine and vitamin C, aggravated by
selenium deficiency, lays the groundwork for the disease
when the oxidant load increases upon regular exposure to
environmental chemicals which induce cytochrome P-450
mono-oxygenases (17). Comparing clinical and
biochemical data from three consecutive 20-week
placebo-controlled double-blind switchover trials using
different treatments, the combination of methionine or
sulphadenosyl-methionine (SAMe) and vitamin C was
identified as the key to success (18-22), while it was
noted that patients with severe pain had the lowest values
of serum selenium (21). Further, the potential usefulness
of the same approach in patients with hereditary
pancreatitis was raised when affected family members
were found to have poorer antioxidant blood profiles
than their asymptomatic counterparts (23). In 2001,
Uomo et al. (24) reported the usefulness of antioxidant
4
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therapy in a non-controlled study based on three patients
affected by hereditary chronic pancreatitis. The two-year
study was divided into four six-month periods. In the first
and third periods, an oral analgesic drug was
administered on demand, whereas in the second and
fourth periods, oral antioxidant therapy was
administered. The therapy consisted of SAMe (800 mg
per day), vitamin C (180 mg per day), vitamin E (130 mg
per day), vitamin A (2400 µg per day), and selenium (75
µg per day). Patient compliance to the treatment was
satisfactory and no side effects were observed; the
treatment with antioxidants brought about a meaningful
reduction in the number of days of pain in both periods
of antioxidant treatment and a meaningful reduction of
daily analgesic consumption. The authors concluded that
oxidative stress is one of the main factors determining
pain in hereditary chronic pancreatitis and that oral
administration of antioxidants seems to be effective in the
control of the pain.
Even if the cost of this therapy is not excessively high,
the search to achieve a cost reduction in less economically
developed countries has led to the identification of natural
extracts having the same power as commercially available
antioxidants. Japanese authors (25) have suggested that
the extract of the Curcuma Longa, a perennial herbaceous
plant which can grow as high as one meter and
constitutes a part of curry, named curcumin, exhibits
strong antioxidant activity comparable to that of vitamins
C and E. However, curcumin is poorly absorbed following
oral administration (26). Absorption can be improved by
the co-administration of piperine (from black pepper)
increasing the bioavailability by 2000% in rats and
humans, without precipitating any adverse effects (27).
Based on these assumptions, Indian authors have
undertaken a pilot study in order to evaluate the effect of
the association of curcumin and piperine administered
orally on the possible reduction of pain in patients with
tropical pancreatitis (28). They studied 20 consecutive
patients with tropical pancreatitis randomized into two
groups. One group received 500 mg of curcumin and 5
mg of piperine for six weeks and the second group
received a placebo for an identical period of time. The
effects of the two treatments on the pattern of pain and
on the red blood cell levels of malonyldialdehyde (MDA)
and glutathione (GSH) were evaluated. There was a
significant reduction in the erythrocyte MDA levels
following curcumin therapy as compared to the placebo
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and a significant increase in GSH levels, but there was no
corresponding improvement in pain.
The question which arises from the studies of Uomo
et al. (24) and Durgaprasad et al. (28) is why such
differences exist in pain control using antioxidant
treatment. One possible explanation is that the SAMe and
the selenium were not used in the Indian study and this
may have, in some way, modified the pain control which
clearly improved in the Italian study (24). This hypothesis
is supported by the study carried out in England and
performed using the Antox tablet, which contains 75 mg
of selenium, 3 mg beta-carotene, 47 mg d-alphatocopherol acetate (vitamin E), 150 mg ascorbic acid
(vitamin C), and 400 mg methionine (29). In this
randomized, double-blind, placebo-controlled crossover
trial, the efficacy of a combined antioxidant preparation in
the management of chronic pancreatitis was evaluated.
Patients with proven chronic pancreatitis were
randomized to receive treatment with either Antox or a
placebo for 10 weeks. Each group of patients then
switched to receive the alternative treatment for a
further 10 weeks. Markers of antioxidant status were
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measured by blood sampling, whereas quality of life and
pain were assessed using the SF-36 questionnaire.
Nineteen patients completed the full 20 weeks of
treatment. Treatment with Antox was associated with
significant improvement in the quality of life in terms of
pain, physical and social functioning, and general health
perception. The treatment with antioxidants seems to
confirm the data obtained by Uomo et al. (24) in reducing
pain in patients suffering from chronic pancreatitis.

Conclusions
Antioxidant treatment may become a useful tool in
preventing and curing the pain in patients with chronic
pancreatitis. However, large randomized studies are
needed in order to definitively assess the usefulness and
the best combination of antioxidants in patients with
chronic pancreatitis; moreover, it must be kept in mind
that the quality of life of the patients who receive such
treatment should also be carefully and objectively
measured.
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